Notably, the constitutive splicing of XBP1 mRNA and expression of XBP1s protein in AMO1 myeloma cells were inhibited in a dose-dependent manner following an exposure to periplocin (Fig. 4a). The gene discussed is XBP1; the disease is plasma cell myeloma.